SEI Investments’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $258K | Buy |
20,093
+2,316
| +13% | +$29.5K | ﹤0.01% | 2876 |
|
|
2025
Q4 | $160K | Sell |
17,777
-16,974
| -49% | -$234K | ﹤0.01% | 2949 |
|
|
2025
Q3 | $600K | Buy |
34,751
+8,476
| +32% | +$104K | ﹤0.01% | 2155 |
|
|
2025
Q2 | $247K | Buy |
26,275
+9,739
| +59% | +$80K | ﹤0.01% | 2485 |
|
|
2025
Q1 | $118K | Buy |
+16,536
| New | +$167K | ﹤0.01% | 2572 |
|
|
2024
Q4 | – | Sell |
-19,844
| Closed | -$408K | – | 2769 |
|
|
2024
Q3 | $408K | Buy |
19,844
+10,562
| +114% | +$244K | ﹤0.01% | 2247 |
|
|
2024
Q2 | $208K | Buy |
9,282
+1,837
| +25% | +$43.7K | ﹤0.01% | 2447 |
|
|
2024
Q1 | $205K | Buy |
7,445
+470
| +7% | +$13.1K | ﹤0.01% | 2421 |
|
|
2023
Q4 | $213K | Sell |
6,975
-1,220
| -15% | -$35.1K | ﹤0.01% | 2425 |
|
|
2023
Q3 | $259K | Buy |
8,195
+506
| +7% | +$19.6K | ﹤0.01% | 2353 |
|
|
2023
Q2 | $314K | Buy |
+7,689
| New | +$312K | ﹤0.01% | 2321 |
|
|
2022
Q4 | – | Sell |
-9,236
| Closed | -$517K | – | 2634 |
|
|
2022
Q3 | $517K | Buy |
9,236
+2,511
| +37% | +$156K | ﹤0.01% | 2071 |
|
|
2022
Q2 | $348K | Buy |
+6,725
| New | +$341K | ﹤0.01% | 2259 |
|
|
2022
Q1 | – | Sell |
-3,565
| Closed | -$422K | – | 2626 |
|
|
2021
Q4 | $422K | Sell |
3,565
-9,905
| -74% | -$1.24M | ﹤0.01% | 2198 |
|
|
2021
Q3 | $1.81M | Sell |
13,470
-621
| -4% | -$94K | ﹤0.01% | 1546 |
|
|
2021
Q2 | $2.28M | Buy |
+14,091
| New | +$1.1M | 0.01% | 1461 |
|
|
2018
Q4 | – | Sell |
-4,745
| Closed | -$80K | – | 2661 |
|
|
2018
Q3 | $80K | Sell |
4,745
-1,121
| -19% | -$32.6K | ﹤0.01% | 2131 |
|
|
2018
Q2 | $160K | Buy |
5,866
+5,066
| +633% | +$123K | ﹤0.01% | 2132 |
|
|
2018
Q1 | $17K | Buy |
+800
| New | +$19.7K | ﹤0.01% | 2699 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
